Skip to main content
Clinical Trials/DRKS00020137
DRKS00020137
Completed
Not Applicable

Identification of miRNA biomarker signature for diagnosis and monitoring of lung cancer - PULmiR Study

Hummingbird Diagnostics GmbH0 sites1,000 target enrollmentFebruary 18, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
C34
Sponsor
Hummingbird Diagnostics GmbH
Enrollment
1000
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 18, 2020
End Date
August 31, 2023
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Male or female, \=40 years old, therapy naïve, suspicious to lung cancer or other lung disease, sufficient knowledge of German, willingness to participate in the study

Exclusion Criteria

  • Known infectious diseases (HIV, HCV, HBV), advanced, curatively\-treated cancer within last 5 years, past diagnosed lung cancer

Outcomes

Primary Outcomes

Not specified

Similar Trials